TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06305663: A Multi-center, Randomized, Parallel, Bilateral, Investigator-masked Study to Evaluate the Safety and Efficacy of the Bausch + Lomb Myopia Control Lens for the Correction of Myopic Ametropia and Slowing the Progression o

Sponsor: Bausch & Lomb Incorporated · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 418 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$7,669,200

Rescue Site Savings

+$5,046,400

Unlock Full NCT06305663 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06305663 Rescue Dossier →